ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—2024 update - Malcikova, Jitka; Pavlova, Sarka; Baliakas, Panagiotis; Chatzikonstantinou, Thomas; Tausch, Eugen; Catherwood, Mark; Rossi, Davide; Soussi, Thierry; Tichy, Boris; Kater, Arnon P.; Niemann, Carsten U.; Davi, Frederic; et al. (Leukemia, 2024)
Keywords: 45/23; 631/67/395; 692/499; Aberration; Algorithms; Cancer Research; Chronic lymphocytic leukemia; Clinical trials; Cloning; Critical Care Medicine; Decision making; DNA Mutational Analysis - methods; DNA Mutational Analysis - standards; Gene deletion; Gene frequency; Health services; Hematology; High-Throughput Nucleotide Sequencing - methods; Humans; Intensive; Internal Medicine; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis; Leukemia, Lymphocytic, Chronic, B-Cell - genetics; Medicine; Medicine & Public Health; Mutation; Next-generation sequencing; Oncology; p53 Protein; Patients; Review; Review Article; Risk reduction; Tumor Suppressor Protein p53 - genetics